申请人:Metabio-Joullie
公开号:US04203986A1
公开(公告)日:1980-05-20
Compounds of the formula I ##STR1## wherein R.sub.1 represents a hydrogen or fluorine atom, and R.sub.2 represents an alkyl group containing 2 to 6 carbon atoms, or a cycloalkyl or cycloalkyl-alkyl group containing 5 to 8 carbon atoms, each of these groups being substituted by one or two hydroxy groups or an oxo group and, if desired, also by a 4-(m-trifluoromethylphenyl)-piperazino or 4-(3-trifluoromethyl-4-fluoro-phenyl)-piperazino group with the proviso that, when R.sub.1 represents a hydrogen atom, R.sub.2 does not represent a monohydroxyalkyl group, and their pharmaceutically acceptable acid addition salts are novel and have therapeutic use, notably in the region of the central nervous system and in the cardiovascular region.
化合物I的式子为##STR1## 其中R.sub.1代表氢或氟原子,R.sub.2代表含有2到6个碳原子的烷基或含有5到8个碳原子的环烷基或环烷基烷基,这些基团中的每一个都被一个或两个羟基或一个氧代基取代,如果需要,还可以通过一个4-(m-三氟甲基苯基)-哌嗪或4-(3-三氟甲基-4-氟苯基)-哌嗪基团进行取代,但是当R.sub.1代表氢原子时,R.sub.2不代表单羟基烷基,它们的药学上可接受的酸盐是新颖的,并且具有治疗作用,特别是在中枢神经系统和心血管区域。